A critical discovery in cancer research is occurring with the use of mini-antibodies to re-engage damaged p53. This vital tumor suppressor protein is frequently disabled in several kinds of cancer, resulting https://digibookmarks.com/story21886163/vhh-fragments-reactivate-the-p53-protein-new-new-hope-for-tumor-management